4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines

por Gay, Martha, Safronenka, Anita, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Kruger, Annie, Smith, Jill
Publicado 2020

25380 Cholecystokinin-B Receptor -Mediates Growth of Hepatocellular Carcinoma

por Gay, Martha Dee, Safronenka, Anita, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Smith, Jill P.
Publicado 2021

4121 The beneficial, anti-fibrotic effects of chemokine receptor 2 and 5 antagonists on fat-exposed mouse primary hepatic stellate cells (pHSCs)

por Kruger, Annie J., Bergman, Kruger, Gay, Martha, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Smith, Jill P.
Publicado 2020

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome

por Gay, Martha D., Cao, Hong, Shivapurkar, Narayan, Dakshanamurthy, Sivanesan, Kallakury, Bhaskar, Tucker, Robin D., Kwagyan, John, Smith, Jill P.
Publicado 2022

Educational initiative in an NCATS TL1 training program to address the impact of systemic racism on human health, biomedical research, and the translational scientist

por Gay, Martha D., Bell, Kimberly A., Bujold, Emily A., Geraci, Marilla, Lee, Dexter L., Sandberg, Kathryn, Speth, Robert C.
Publicado 2022

Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment

por Hsu, Christine C., Bansal, Sunil, Cao, Hong, Smith, Coleman I., He, Aiwu Ruth, Gay, Martha D., Li, Yaoxiang, Cheema, Amrita, Smith, Jill P.
Publicado 2022

Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma

por Shivapurkar, Narayan, Gay, Martha D., He, Aiwu (Ruth), Chen, Wenqiang, Golnazar, Shermineh, Cao, Hong, Duka, Tetyana, Kallakury, Bhaskar, Vasudevan, Sona, Smith, Jill P.
Publicado 2023

Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment

por Malchiodi, Zoe X., Cao, Hong, Gay, Martha D., Safronenka, Anita, Bansal, Sunil, Tucker, Robin D., Weinberg, Benjamin A., Cheema, Amrita, Shivapurkar, Narayan, Smith, Jill P.
Publicado 2021

Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis

por Rabiee, Atoosa, Gay, Martha D., Shivapurkar, Narayan, Cao, Hong, Nadella, Sandeep, Smith, Coleman I., Lewis, James H., Bansal, Sunil, Cheema, Amrita, Kwagyan, John, Smith, Jill P.
Publicado 2022

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma

por Tucker, Robin D., Ciofoaia, Victor, Nadella, Sandeep, Gay, Martha D., Cao, Hong, Huber, Matthew, Safronenka, Anita, Shivapurkar, Narayan, Kallakury, Bhaskar, Kruger, Annie J., Kroemer, Alexander H. K., Smith, Jill P.
Publicado 2019